Agrawal M
Sunstone Therapies (M.A., M.K.L., C.L.), Rockville, Maryland.
ArticlePsilocybin
Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis.
ArticlePsilocybin
Developing Methods for Observing Awe Narration in Psilocybin-Assisted Therapy.
ArticleMDMA
Psychodynamic Perspectives on Psychedelic States and Treatment Contexts: A Conceptual and Clinical Introduction.
ArticlePsilocybin
Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.
ArticlePsilocybin
Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.
ArticlePsilocybin
Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.
ArticlePsilocybin
Meaning-Centered Psychotherapy for Psilocybin-Assisted Therapy Among Patients with Advanced Cancer and Depression: Rationale and Preliminary Evaluation of MCP-PSIL.
ArticlePsilocybin
Long-term benefits of single-dose psilocybin in depressed patients with cancer.
ArticlePsychedelics
Adverse Events Should Not Be Surprising in Psychedelic Research.
ArticlePsilocybin
Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.
ArticlePsilocybin
Group psychedelic therapy: empirical estimates of cost-savings and improved access.
ArticlePsilocybin
Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study.
ArticlePsilocybin
Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients.
ArticlePsychedelics